Live feed
·
PRReleasevia Quantisnow
iBio Inc. logo

iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

ByQuantisnow·Wall Street's wire, on your screen.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IBIO (iBio Inc.) and more on Quantisnow.